The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

Transportation Secretary Sean Duffy says he plans to reduce the number of flights in and out of Newark’s airport for the ...

Five different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer ...

In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

As soon as it becomes possible to consider using eye drops, everyone who regularly uses them should start doing a ...

All the schools in these areas were closed after Pakistan began intense artillery shelling following India's launch of ...

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Vinay Prasad will replace Marks as CBER director Trump's budget would be "catastrophic" for federal R&D Pharma still in waiting mode after UK-US trade agreement ...